ライフサイエンスコーパス: prophylactic antibiotics

1 reoperative wIRA as a supportive addition to prophylactic antibiotics.

2 locyte colony-stimulating factor support and prophylactic antibiotics.

3 ; controversy remains with respect to use of prophylactic antibiotics.

4 re are associated with improved provision of prophylactic antibiotics.

5 aboratory employee was pregnant and declined prophylactic antibiotics.

6 rtion, with or without the administration of prophylactic antibiotics.

7 Few participants received prophylactic antibiotics.

8 1, which supports the decision to administer prophylactic antibiotics.

9 ients with severe acute pancreatitis receive prophylactic antibiotics?

10 We recommend that routine use of prophylactic antibiotics after IVT injection be discoura

11 the risks of extrinsic factors by the use of prophylactic antibiotics and best clinical practices.

12 ticulous planning with regard to appropriate prophylactic antibiotics and body position will maximize

13 Several studies have reported that prophylactic antibiotics and imaging studies after first

14 Prophylactic antibiotics and interferon gamma have reduc

15 The recommendations also suggest that prophylactic antibiotics and surgery should be avoided i

16 interval [CI], 2.3-21.7) additional days of prophylactic antibiotics, and each emergency department

17 py home support included intravenous fluids, prophylactic antibiotics, and granulocyte colony-stimula

18 haematological malignancies and/or receiving prophylactic antibiotics, and in the development of fact

19 treatment of rejection episodes, the use of prophylactic antibiotics, and the schedule for cardiac b

20 iver Disease score or diabetes, those taking prophylactic antibiotics, and those with prior HE were m

21 Routine prophylactic antibiotics are not indicated in infants wi

22 It is still unproven whether prophylactic antibiotics can reduce mortality from acute

23 Recent research confirms that prophylactic antibiotics decrease febrile neutropenia an

24 Prophylactic antibiotics did not affect the incidence of

25 uld require the routine use of postoperative prophylactic antibiotics following eyelid surgery.

26 d the units (1:1) by computer to give either prophylactic antibiotics for 7 days plus standard stroke

27 A strict policy, since 1991, of prophylactic antibiotics for the first 6 months has halv

28 patient morbidity, and the benefits of using prophylactic antibiotics have not been proven.

29 rols and in the three trials with concurrent prophylactic antibiotics in both treatment arms.

30 ptococcal (iGAS) infection, and the need for prophylactic antibiotics in close contacts, remains cont

31 ive decontamination, short-course parenteral prophylactic antibiotics in high-risk patients) and the

32 es have further underlined the usefulness of prophylactic antibiotics in severe acute pancreatitis.

33 se procedures that are resistant to standard prophylactic antibiotics in the USA.

34 after chemotherapy are resistant to standard prophylactic antibiotics in the USA.

35 The use of prophylactic antibiotics in these patients and the mecha

36 f further studies, provide an alternative to prophylactic antibiotics in this type of surgery.

37 Prophylactic antibiotics including antiviral, antifungal

38 Antacids and prophylactic antibiotics (intravenous penicillin, topica

39 portive care that included administration of prophylactic antibiotics, management of neutropenic feve

40 emotherapy is active in B-precursor ALL, and prophylactic antibiotics may be useful in reducing morta

41 ith bleeding related to portal hypertension, prophylactic antibiotics may decrease the risk of infect

42 Controversy exists about the impact of prophylactic antibiotics on bacteremia after invasive de

43 Patients were treated with prophylactic antibiotics on days 5 through 15.

44 Prophylactic antibiotics or aspirin can reduce but not p

45 after colectomy, including SCIP-2-compliant prophylactic antibiotics, postoperative normothermia, gl

46 in subjects in the RIVUR Study randomized to prophylactic antibiotics, providing evidence that copy n

47 Enhanced supportive care and prophylactic antibiotics should be considered in high-ri

48 The main current strategy is the use of prophylactic antibiotics targeted at specific subpopulat

49 residents received pneumococcal vaccine and prophylactic antibiotics, there were no additional cases

50 om aggressive imaging studies and the use of prophylactic antibiotics to a more restrictive and targe

51 The use of prophylactic antibiotics to decrease the incidence of SB

52 rs with sickle cell disease (SCD) take daily prophylactic antibiotics to prevent pneumococcal infecti

53 questioned the traditional approach of using prophylactic antibiotics to prevent recurrence of UTI an

54 costs incurred during 1-year treatment with prophylactic antibiotics vs. no prophylaxis in patients

55 age, weight group, risk stratification, and prophylactic antibiotics was used to estimate the impact

56 Of the 32,459 operations, prophylactic antibiotics were administered at a median o

57 Granulocyte colony-stimulating factor and prophylactic antibiotics were administered for all eight

58 e procedures, antacids, enteral feeding, and prophylactic antibiotics were administered.

59 Prophylactic antibiotics were required.